Advanced transitional-cell carcinoma of the bladder is the most common cancer ... Nevertheless, 40–50% of patients have impaired renal function that precludes the use of cisplatin.
There was a lack of effective, cell-free biomaterials for bladder tissue regeneration that could reliably restore function without the complexities and risks of cell-seeded scaffolds. The breakthrough ...
Disappointingly, some children without bladder impairment showed a deterioration of bladder function after surgery, which critically influences the health-related quality of life. It was hypothesized ...
The most common reason for cisplatin-ineligibility is renal function impairment. Up to 40% of patients with bladder cancer have renal impairment, defined as a creatinine clearance ≤60 ml/min ...
Get Instant Summarized Text (Gist) An electroactive "scaffolding" biomaterial has been developed to enhance bladder tissue regeneration and function, outperforming current methods. This cell-free ...
Bladder cancer can be curable, and the likelihood of cure is higher if it is diagnosed at an early stage. Without treatment, bladder cancer does not go away on its own, and treatment is associated ...